Inhibition of these co-stimulatory molecules using CTLA-4-Fc in experimental autoimmune encephalomyelitis, an animal model of MS, has been effective in decreasing inflammation and demyelination [43], but there are few reports on NMOSD. The gene discussed is CTLA4; the disease is experimental autoimmune encephalomyelitis.